Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 11


Results: 47
    1

    The Corruption of Science.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 907, doi. 10.1002/onco.13549
    By:
    • Chabner, Bruce A.
    Publication type:
    Article
    2

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1819, doi. 10.1002/onco.13538
    By:
    • Vivaldi, Caterina;
    • Fornaro, Lorenzo;
    • Ugolini, Clara;
    • Vasile, Enrico
    Publication type:
    Article
    3
    4
    5

    Professional Medical Writer Assistance in Oncology Clinical Trials.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1812, doi. 10.1634/theoncologist.2020-0406
    By:
    • Kouzy, Ramez;
    • Abi Jaoude, Joseph;
    • Mainwaring, Walker;
    • Lin, Timothy A.;
    • Miller, Austin B.;
    • Jethanandani, Amit;
    • Espinoza, Andres F.;
    • Verma, Vivek;
    • Fuller, Clifton D.;
    • Minsky, Bruce D.;
    • Rödel, Claus;
    • Taniguchi, Cullen M.;
    • Ludmir, Ethan B.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD‐L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 943, doi. 10.1634/theoncologist.2020-0449
    By:
    • Huang, Richard S.P.;
    • Li, Xinyan;
    • Haberberger, James;
    • Sokol, Ethan;
    • Severson, Eric;
    • Duncan, Daniel L.;
    • Hemmerich, Amanda;
    • Edgerly, Claire;
    • Williams, Erik;
    • Elvin, Julia;
    • Vergilio, Jo‐Anne;
    • Killian, Jonathan Keith;
    • Lin, Douglas;
    • Hiemenz, Matthew;
    • Xiao, Jinpeng;
    • McEwan, Deborah;
    • Holmes, Oliver;
    • Danziger, Natalie;
    • Erlich, Rachel;
    • Frampton, Garrett
    Publication type:
    Article
    11
    12
    13
    14

    A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 963, doi. 10.1634/theoncologist.2019-0986
    By:
    • Yu, Li;
    • Shi, Menghan;
    • Cai, Qingqing;
    • Strati, Paolo;
    • Hagemeister, Fredrick;
    • Zhai, Qiongli;
    • Li, Ling;
    • Fang, Xiaosheng;
    • Li, Jianyong;
    • Sun, Ruifang;
    • Zhang, Shanxiang;
    • Yang, Hanjin;
    • Wang, Zhaoming;
    • Qian, Wenbin;
    • Iwaki, Noriko;
    • Sato, Yasuharu;
    • Zhang, Lu;
    • Li, Jian;
    • Oksenhendler, Eric;
    • Xu‐Monette, Zijun Y.
    Publication type:
    Article
    15

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1817, doi. 10.1634/theoncologist.2020-0627
    By:
    • Wolf, Ido;
    • Waissengrin, Barliz;
    • Pelles, Sharon
    Publication type:
    Article
    16

    Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET‐Amplified Esophagogastric Cancers.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1691, doi. 10.1634/theoncologist.2020-0274
    By:
    • Chaudhary, Surendra Pal;
    • Kwak, Eunice L.;
    • Hwang, Katie L.;
    • Lennerz, Jochen K.;
    • Corcoran, Ryan B.;
    • Heist, Rebecca S.;
    • Russo, Andrea L.;
    • Parikh, Aparna;
    • Borger, Darrell R.;
    • Blaszkowsky, Lawrence S.;
    • Faris, Jason E.;
    • Murphy, Janet E.;
    • Azzoli, Christopher G.;
    • Roeland, Eric J.;
    • Goyal, Lipika;
    • Allen, Jill;
    • Mullen, John T.;
    • Ryan, David P.;
    • Iafrate, A. John;
    • Klempner, Samuel J.
    Publication type:
    Article
    17

    Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 954, doi. 10.1634/theoncologist.2020-0474
    By:
    • Bendell, Johanna;
    • Sharma, Sunil;
    • Patel, Manish R.;
    • Windsor, Kevin S.;
    • Wainberg, Zev A.;
    • Gordon, Michael;
    • Chaves, Jorge;
    • Berlin, Jordan;
    • Brachmann, Carrie Baker;
    • Zavodovskaya, Marianna;
    • Liu, JieJane;
    • Thai, Dung;
    • Bhargava, Pankaj;
    • Shah, Manish A.;
    • Khan, Saad A.;
    • Starodub, Alexander
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    The Art of Oncology: COVID‐19 Era.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 997, doi. 10.1634/theoncologist.2020-0512
    By:
    • Reynolds, Kerry L.;
    • Klempner, Samuel J.;
    • Parikh, Aparna;
    • Hochberg, Ephraim P.;
    • Michaelson, M. Dror;
    • Mooradian, Meghan J.;
    • Lee, Richard J.;
    • Soumerai, Tara E.;
    • Hobbs, Gabriela;
    • Piotrowska, Zofia;
    • Sykes, David B.;
    • Farago, Anna F.;
    • Bardia, Aditya;
    • Rosovsky, Rachel P.;
    • Ryan, David P.
    Publication type:
    Article
    27

    A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1655, doi. 10.1634/theoncologist.2020-0679
    By:
    • Riedel, Richard F.;
    • Ballman, Karla V.;
    • Lu, Yao;
    • Attia, Steven;
    • Loggers, Elizabeth T.;
    • Ganjoo, Kristen N.;
    • Livingston, Michael B.;
    • Chow, Warren;
    • Wright, Jennifer;
    • Ward, John H.;
    • Rushing, Daniel;
    • Okuno, Scott H.;
    • Reed, Damon R.;
    • Liebner, David A.;
    • Keedy, Vicki L.;
    • Mascarenhas, Leo;
    • Davis, Lara E.;
    • Ryan, Christopher;
    • Reinke, Denise K.;
    • Maki, Robert G.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35

    The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1777, doi. 10.1634/theoncologist.2020-0352
    By:
    • Baldi, Giacomo Giulio;
    • Brahmi, Mehdi;
    • Lo Vullo, Salvatore;
    • Cojocaru, Elena;
    • Mir, Olivier;
    • Casanova, Michela;
    • Vincenzi, Bruno;
    • De Pas, Tommaso Martino;
    • Grignani, Giovanni;
    • Pantaleo, Maria Abbondanza;
    • Blay, Jean Yves;
    • Jones, Robin Lewis;
    • Le Cesne, Axel;
    • Frezza, Anna Maria;
    • Gronchi, Alessandro;
    • Collini, Paola;
    • Dei Tos, Angelo Paolo;
    • Morosi, Carlo;
    • Mariani, Luigi;
    • Casali, Paolo Giovanni
    Publication type:
    Article
    36
    37
    38

    Apatinib plus Chemotherapy as a Second‐Line Treatment in Unresectable Non‐Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1640, doi. 10.1634/theoncologist.2020-0519
    By:
    • Yu, Zongyang;
    • Cai, Xiuyu;
    • Xu, Zhengwu;
    • He, Zhiyong;
    • Lai, Jinhuo;
    • Wang, Wenwu;
    • Zhang, Jing;
    • Kong, Wencui;
    • Huang, Xiaoyan;
    • Chen, Ying;
    • Shi, Yanhong;
    • Shi, Xi;
    • Zhao, Zhongquan;
    • Ni, Min;
    • Lin, Xiangwu;
    • Chen, Siyu;
    • Wu, Xiaolong;
    • Chen, Wujin;
    • Song, Zhengbo;
    • Huang, Cheng
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    A Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 925, doi. 10.1634/theoncologist.2020-0367
    By:
    • El Dika, Imane;
    • Mayer, Robert J.;
    • Venook, Alan P.;
    • Capanu, Marinela;
    • LaQuaglia, Michael P.;
    • Kobos, Rachel;
    • O'Neill, Allison F.;
    • Chou, Joanne F.;
    • Ly, Michele;
    • Ang, Celina;
    • O'Reilly, Eileen M.;
    • Gordan, John D.;
    • Abou‐Alfa, Ghassan K.
    Publication type:
    Article
    45

    Do I Know You?

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 993, doi. 10.1634/theoncologist.2020-0117
    By:
    • Murphy, Martina
    Publication type:
    Article
    46
    47

    The Predictive Value of Early Changes in <sup>18</sup>F‐Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor‐Positive Metastatic Breast Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 927, doi. 10.1634/theoncologist.2019-0561
    By:
    • He, Min;
    • Liu, Cheng;
    • Shi, Qin;
    • Sun, Yuyun;
    • Zhang, Yongping;
    • Xu, Xiaoping;
    • Yuan, Huiyu;
    • Zhang, Yingjian;
    • Liu, Yin;
    • Liu, Guangyu;
    • Di, Genhong;
    • Yang, Zhongyi;
    • Wang, Zhonghua;
    • Shao, Zhiming
    Publication type:
    Article